Previous Close
$0.7061
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$2.5 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical cand...
Community
- 0 posts discussing
0
Watchers
0
Visitors